Hepatitis C News and Research

Latest Hepatitis C News and Research

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Roche launches cobas TaqScreen DPX Test for parvovirus B19 and hepatitis A virus

Merck reports GAAP net income of $861 million for 2010

Merck reports GAAP net income of $861 million for 2010

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Cell signaling hormone boosts immune response to clear HIV-like infection

Cell signaling hormone boosts immune response to clear HIV-like infection

Tacere announces reacquisition of HCV compound development, commercialization rights in Asia

Tacere announces reacquisition of HCV compound development, commercialization rights in Asia

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

New study examines role of later acquisition of hepatitis C in HIV patients

New study examines role of later acquisition of hepatitis C in HIV patients

Current prevention efforts delay but do not prevent HCV among injection drug users

Current prevention efforts delay but do not prevent HCV among injection drug users

Bill Gates, crown prince of Abu Dhabi announce $100m pledge for vaccines for Afghan, Pakistani children

Bill Gates, crown prince of Abu Dhabi announce $100m pledge for vaccines for Afghan, Pakistani children

Fibroblasts help 'recruit' immune cells for tumor growth

Fibroblasts help 'recruit' immune cells for tumor growth

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Anadys begins dosing in ANA598 Phase IIb study for hepatitis C

Anadys begins dosing in ANA598 Phase IIb study for hepatitis C

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

Evaluating patients for genetic variations impacts adherence to antiviral therapy

Evaluating patients for genetic variations impacts adherence to antiviral therapy

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

CRI, Oncovir sign new investment agreement to produce immunological stimulant

CRI, Oncovir sign new investment agreement to produce immunological stimulant

CVAF completes new investment agreement with Oncovir for production of Hiltonol

CVAF completes new investment agreement with Oncovir for production of Hiltonol

Pharmasset prices underwritten public offering of 3,300,000 shares of common stock

Pharmasset prices underwritten public offering of 3,300,000 shares of common stock

Opinions: GAVI; Haitian women; Clinton's foreign policy

Opinions: GAVI; Haitian women; Clinton's foreign policy

FDA accepts Vertex's telaprevir NDA for six-month Priority Review

FDA accepts Vertex's telaprevir NDA for six-month Priority Review

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.